Decreased Expression of CD95 (FAS/APO-1) on CD4+ T-lymphocytes from Participants with Autism

被引:0
|
作者
Henrik A. Engstrom
Sten Ohlson
E. Gene Stubbs
Alma Maciulis
Virgil Caldwell
J. Dennis Odell
Anthony R. Torres
机构
[1] University of Kalmar,Department of Chemistry and Biomedical Sciences
[2] University of Oregon,Child Development and Rehabilitation Center
[3] Utah State University,Center for Persons with Disabilities, Biology Department
关键词
autism; apoptosis; FAS; CD95; APO-1;
D O I
暂无
中图分类号
学科分类号
摘要
Although autism remains an enigmatic disease, there is mounting evidence that the immune system plays an important role in the pathogenesis. Immune system involvement is apparently widespread as numerous humoral and cellular abnormalities have been reported in both the innate and adaptive responses. Fas (CD95/APO-1) is a type I cell-surface protein from the TNF/NGF-R superfamily present on the surface of many immune related cells. Fas activation is instrumental in starting a complicated chain of events that results in programmed cell death (apoptosis) by DNA fragmentation. Preliminary data is presented, which indicate that subjects with austism have lower levels of Fas on their CD4+ helper T cells (p = .048) than have normal subjects. Data also indicates subjects with autism have significantly higher levels of soluble Fas (p = .01) than have normal subjects. A maturing individual must eliminate cells for proper morphogenesis to occur. Preliminary data suggest that faulty apoptosis may be involved in the pathogenesis of autism.
引用
收藏
页码:155 / 163
页数:8
相关论文
共 50 条
  • [1] Decreased expression of CD95 (FAS/APO-1) on CD4+ T-lymphocytes from participants with autism
    Engstrom, HA
    Ohlson, S
    Stubbs, EG
    Maciulis, A
    Caldwell, V
    Odell, JD
    Torres, AR
    JOURNAL OF DEVELOPMENTAL AND PHYSICAL DISABILITIES, 2003, 15 (02) : 155 - 163
  • [2] Decreased expression of Fas (APO-1/CD95) on peripheral blood CD4+T lymphocytes in cutaneous T-cell lymphomas
    Dereure, O
    Portales, P
    Clot, J
    Guilhou, JJ
    BRITISH JOURNAL OF DERMATOLOGY, 2000, 143 (06) : 1205 - 1210
  • [3] Decreased expression of Fas (APO-1/CD95) on lesional CD4+T lymphocytes in cutaneous T cell lymphomas: correlations with blood data
    Dereure, O
    Portales, P
    Clot, J
    Guilhou, JJ
    BRITISH JOURNAL OF DERMATOLOGY, 2001, 145 (06) : 1031 - 1032
  • [4] Decreased expression of Fas (Apo-1/Cd95) on lesional CD4+T lymphocytes in cutaneous T cell lymphomas: Correlations with blood data
    Dereure, O
    Portales, P
    Clot, J
    Guilhou, JJ
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 118 (05) : 904 - 904
  • [5] Fas/APO-1 (CD95) expression in myelodysplastic syndromes
    Lepelley, P
    Grardel, N
    Erny, O
    Iaru, T
    Obein, V
    Cosson, A
    Fenaux, P
    LEUKEMIA & LYMPHOMA, 1998, 30 (3-4) : 307 - 312
  • [6] Fas/APO-1 (CD95) expression of peripheral T lymphocytes (Ly) in colorectal cancer patients
    Donina, S
    Engele, L
    Jaunalksne, I
    Januskevics, V
    Zakenfelds, G
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S12 - S12
  • [7] The CD95(APO-1/Fas)/CD95L system
    Krammer, PH
    TOXICOLOGY LETTERS, 1998, 103 : 131 - 137
  • [8] The CD95(APO-1/Fas) DISC and beyond
    M E Peter
    P H Krammer
    Cell Death & Differentiation, 2003, 10 : 26 - 35
  • [9] CD95(apo-1/fas) signalling and diseases
    Krammer, PH
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2003, 367 : R1 - R1
  • [10] The CD95(APO-1/Fas) DISC and beyond
    Peter, ME
    Krammer, PH
    CELL DEATH AND DIFFERENTIATION, 2003, 10 (01): : 26 - 35